Impaired pre-mRNA processing and altered architecture of 3' untranslated regions contribute to the development of human disorders

International Journal of Molecular Sciences

Volumn 14, Issue 8, 2013, Pages 15681-15694

  Hrstka, Roman ^a   Michalova, Eva ^a   Vojtesek, Borivoj ^a  

^a MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

Author keywords

3'UTR; Cancer; Mutation; Polymorphism; Trinucleotide repeat expansion

Indexed keywords

MESSENGER RNA PRECURSOR;

3' UNTRANSLATED REGION; CARCINOGENESIS; CAUSAL ATTRIBUTION; DISEASE COURSE; FABRY DISEASE; HUMAN; HUNTINGTON DISEASE LIKE SYNDROME; IPEX SYNDROME; MOLECULAR PATHOLOGY; MOOD DISORDER; MUTATIONAL ANALYSIS; MYOTONIC DYSTROPHY; OCULOPHARYNGEAL MUSCULAR DYSTROPHY; PROTEIN CLEAVAGE; PROTEIN SECONDARY STRUCTURE; REGULATORY RNA SEQUENCE; REVIEW; RNA PROCESSING; RNA SPLICING; RNA STABILITY; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVIX CANCER;

3' UNTRANSLATED REGIONS; CHOREA; COGNITION DISORDERS; DEMENTIA; HEREDODEGENERATIVE DISORDERS, NERVOUS SYSTEM; HUMANS; MYOTONIC DYSTROPHY; NEOPLASMS; NUCLEIC ACID CONFORMATION; RNA PRECURSORS; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 84881051665     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140815681     Document Type: Review

References (82)

1. Crick, F. Central dogma of molecular biology. Nature 1970, 227, 561-563.
2. Zhao, J.; Hyman, L.; Moore, C. Formation of mrna 3' ends in eukaryotes: Mechanism, regulation, and interrelationships with other steps in mrna synthesis. Microbiol. Mol. Biol. Rev. 1999, 63, 405-445.
3. Lemay, J.F.; Lemieux, C.; St-Andre, O.; Bachand, F. Crossing the borders: Poly(a)-binding proteins working on both sides of the fence. RNA Biol. 2010, 7, 291-295.
4. Proudfoot, N.J.; Brownlee, G.G. 3' non-coding region sequences in eukaryotic messenger rna. Nature 1976, 263, 211-214.
5. Matoulkova, E.; Michalova, E.; Vojtesek, B.; Hrstka, R. The role of the 3' untranslated region in post-transcriptional regulation of protein expression in mammalian cells. RNA Biol. 2012, 9, 563-576.
6. Higgs, D.R.; Goodbourn, S.E.; Lamb, J.; Clegg, J.B.; Weatherall, D.J.; Proudfoot, N.J. Alpha-thalassaemia caused by a polyadenylation signal mutation. Nature 1983, 306, 398-400.
7. Serjeant, G.R.; Serjeant, B.E.; Fraser, R.A.; Hambleton, I.R.; Higgs, D.R.; Kulozik, A.E.; Donaldson, A. Hb s-beta-thalassemia: Molecular, hematological and clinical comparisons. Hemoglobin 2011, 35, 1-12.
8. Bennett, C.L.; Brunkow, M.E.; Ramsdell, F.; O'Briant, K.C.; Zhu, Q.; Fuleihan, R.L.; Shigeoka, A.O.; Ochs, H.D.; Chance, P.F. A rare polyadenylation signal mutation of the foxp3 gene (aauaaa→aaugaa) leads to the ipex syndrome. Immunogenetics 2001, 53, 435-439.
9. Bell, D.A.; Badawi, A.F.; Lang, N.P.; Ilett, K.F.; Kadlubar, F.F.; Hirvonen, A. Polymorphism in the n-acetyltransferase 1 (nat1) polyadenylation signal: Association of nat1*10 allele with higher n-acetylation activity in bladder and colon tissue. Cancer Res. 1995, 55, 5226-5229.
10. de Leon, J.H.; Vatsis, K.P.; Weber, W.W. Characterization of naturally occurring and recombinant human n-acetyltransferase variants encoded by nat1. Mol. Pharmacol. 2000, 58, 288-299.
11. Harmar, A.J.; Ogilvie, A.D.; Battersby, S.; Smith, C.A.; Blackwood, D.H.; Muir, W.J.; Fink, G.; Goodwin, G.M. The serotonin transporter gene and affective disorder. Cold Spring Harb. Symp. Quant. Biol. 1996, 61, 791-795.
12. Battersby, S.; Ogilvie, A.D.; Blackwood, D.H.; Shen, S.; Muqit, M.M.; Muir, W.J.; Teague, P.; Goodwin, G.M.; Harmar, A.J. Presence of multiple functional polyadenylation signals and a single nucleotide polymorphism in the 3' untranslated region of the human serotonin transporter gene. J. Neurochem. 1999, 72, 1384-1388.
13. Bishop, D.F.; Kornreich, R.; Desnick, R.J. Structural organization of the human alpha-galactosidase a gene: Further evidence for the absence of a 3' untranslated region. Proc. Natl. Acad. Sci. USA 1988, 85, 3903-3907.
14. Brady, R.O.; Gal, A.E.; Bradley, R.M.; Martensson, E.; Warshaw, A.L.; Laster, L. Enzymatic defect in fabry's disease. Ceramidetrihexosidase deficiency. N. Engl. J. Med. 1967, 276, 1163-1167.
15. MacDermot, K.D.; Holmes, A.; Miners, A.H. Natural history of fabry disease in affected males and obligate carrier females. J. Inherit Metab. Dis. 2001, 24, 13-14.
16. Vedder, A.C.; Linthorst, G.E.; van Breemen, M.J.; Groener, J.E.; Bemelman, F.J.; Strijland, A.; Mannens, M.M.; Aerts, J.M.; Hollak, C.E. The dutch fabry cohort: Diversity of clinical manifestations and gb3 levels. J. Inherit Metab. Dis. 2007, 30, 68-78.
17. Tian, B.; Manley, J.L. Alternative cleavage and polyadenylation: The long and short of it. Trends Biochem. Sci. 2013, 38, 312-320.
18. Brown, K.M.; Gilmartin, G.M. A mechanism for the regulation of pre-mrna 3' processing by human cleavage factor im. Mol. Cell 2003, 12, 1467-1476.
19. de Vries, H.; Ruegsegger, U.; Hubner, W.; Friedlein, A.; Langen, H.; Keller, W. Human pre-mrna cleavage factor ii(m) contains homologs of yeast proteins and bridges two other cleavage factors. EMBO J. 2000, 19, 5895-5904.
20. Bienroth, S.; Keller, W.; Wahle, E. Assembly of a processive messenger rna polyadenylation complex. The EMBO J. 1993, 12, 585-594.
21. Gehring, N.H.; Frede, U.; Neu-Yilik, G.; Hundsdoerfer, P.; Vetter, B.; Hentze, M.W.; Kulozik, A.E. Increased efficiency of mrna 3' end formation: A new genetic mechanism contributing to hereditary thrombophilia. Nature Genet. 2001, 28, 389-392.
22. Chen, F.; MacDonald, C.C.; Wilusz, J. Cleavage site determinants in the mammalian polyadenylation signal. Nucleic Acids Res. 1995, 23, 2614-2620.
23. Poort, S.R.; Rosendaal, F.R.; Reitsma, P.H.; Bertina, R.M. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996, 88, 3698-3703.
24. Steinman, R.A. Mrna stability control: A clandestine force in normal and malignant hematopoiesis. Leukemia 2007, 21, 1158-1171.
25. Kerwitz, Y.; Kuhn, U.; Lilie, H.; Knoth, A.; Scheuermann, T.; Friedrich, H.; Schwarz, E.; Wahle, E. Stimulation of poly(a) polymerase through a direct interaction with the nuclear poly(a) binding protein allosterically regulated by rna. EMBO J. 2003, 22, 3705-3714.
26. Brais, B.; Bouchard, J.P.; Xie, Y.G.; Rochefort, D.L.; Chretien, N.; Tome, F.M.; Lafreniere, R.G.; Rommens, J.M.; Uyama, E.; Nohira, O.; et al. Short gcg expansions in the pabp2 gene cause oculopharyngeal muscular dystrophy. Nature Genet. 1998, 18, 164-167.
27. Jenal, M.; Elkon, R.; Loayza-Puch, F.; van Haaften, G.; Kuhn, U.; Menzies, F.M.; Oude Vrielink, J.A.; Bos, A.J.; Drost, J.; Rooijers, K.; et al. The poly(a)-binding protein nuclear 1 suppresses alternative cleavage and polyadenylation sites. Cell 2012, 149, 538-553.
28. Fu, Y.; Sun, Y.; Li, Y.; Li, J.; Rao, X.; Chen, C.; Xu, A. Differential genome-wide profiling of tandem 3' utrs among human breast cancer and normal cells by high-throughput sequencing. Genome Res. 2011, 21, 741-747.
29. Ozsolak, F.; Kapranov, P.; Foissac, S.; Kim, S.W.; Fishilevich, E.; Monaghan, A.P.; John, B.; Milos, P.M. Comprehensive polyadenylation site maps in yeast and human reveal pervasive alternative polyadenylation. Cell 2010, 143, 1018-1029.
30. Shepard, P.J.; Choi, E.A.; Lu, J.; Flanagan, L.A.; Hertel, K.J.; Shi, Y. Complex and dynamic landscape of rna polyadenylation revealed by pas-seq. RNA 2011, 17, 761-772.
31. Ji, Z.; Lee, J.Y.; Pan, Z.; Jiang, B.; Tian, B. Progressive lengthening of 3' untranslated regions of mrnas by alternative polyadenylation during mouse embryonic development. Proc. Natl. Acad. Sci. USA 2009, 106, 7028-7033.
32. de Klerk, E.; Venema, A.; Anvar, S.Y.; Goeman, J.J.; Hu, O.; Trollet, C.; Dickson, G.; den Dunnen, J.T.; van der Maarel, S.M.; Raz, V.; et al. Poly(a) binding protein nuclear 1 levels affect alternative polyadenylation. Nucleic Acids Res. 2012, 40, 9089-9101.
33. Bhattacharjee, R.B.; Zannat, T.; Bag, J. Expression of the polyalanine expansion mutant of nuclear poly(a)-binding protein induces apoptosis via the p53 pathway. Cell Biol. Int. 2012, 36, 697-704.
34. Fu, Y.H.; Pizzuti, A.; Fenwick, R.G., Jr.; King, J.; Rajnarayan, S.; Dunne, P.W.; Dubel, J.; Nasser, G.A.; Ashizawa, T.; de Jong, P.; et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992, 255, 1256-1258.
35. Mahadevan, M.; Tsilfidis, C.; Sabourin, L.; Shutler, G.; Amemiya, C.; Jansen, G.; Neville, C.; Narang, M.; Barcelo, J.; O'Hoy, K.; et al. Myotonic dystrophy mutation: An unstable ctg repeat in the 3' untranslated region of the gene. Science 1992, 255, 1253-1255.
36. Kamsteeg, E.J.; Kress, W.; Catalli, C.; Hertz, J.M.; Witsch-Baumgartner, M.; Buckley, M.F.; van Engelen, B.G.; Schwartz, M.; Scheffer, H. Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2. Eur. J. Hum. Genet. 2012, 20, 1203-1208.
37. Salehi, L.B.; Bonifazi, E.; Stasio, E.D.; Gennarelli, M.; Botta, A.; Vallo, L.; Iraci, R.; Massa, R.; Antonini, G.; Angelini, C.; et al. Risk prediction for clinical phenotype in myotonic dystrophy type 1: Data from 2,650 patients. Genet. Test. 2007, 11, 84-90.
38. Savic Pavicevic, D.; Miladinovic, J.; Brkusanin, M.; Svikovic, S.; Djurica, S.; Brajuskovic, G.; Romac, S. Molecular genetics and genetic testing in myotonic dystrophy type 1. BioMed Res. Int. 2013, doi:10.1155/2013/391821
39. Taneja, K.L.; McCurrach, M.; Schalling, M.; Housman, D.; Singer, R.H. Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J. Cell Biol. 1995, 128, 995-1002.
40. Day, J.W.; Ranum, L.P. Rna pathogenesis of the myotonic dystrophies. Neuromuscul. Disord. 2005, 15, 5-16.
41. Jiang, H.; Mankodi, A.; Swanson, M.S.; Moxley, R.T.; Thornton, C.A. Myotonic dystrophy type 1 is associated with nuclear foci of mutant rna, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum. Mol. Genet. 2004, 13, 3079-3088.
42. Kuyumcu-Martinez, N.M.; Wang, G.S.; Cooper, T.A. Increased steady-state levels of cugbp1 in myotonic dystrophy 1 are due to pkc-mediated hyperphosphorylation. Mol. Cell 2007, 28, 68-78.
43. Kanadia, R.N.; Shin, J.; Yuan, Y.; Beattie, S.G.; Wheeler, T.M.; Thornton, C.A.; Swanson, M.S. Reversal of rna missplicing and myotonia after muscleblind overexpression in a mouse poly(cug) model for myotonic dystrophy, Proc. Natl. Acad. Sci 2006, 103, 11748-11753.
44. Mykowska, A.; Sobczak, K.; Wojciechowska, M.; Kozlowski, P.; Krzyzosiak, W.J. Cag repeats mimic cug repeats in the misregulation of alternative splicing. Nucleic Acids Res. 2011, 39, 8938-8951.
45. Salisbury, E.; Sakai, K.; Schoser, B.; Huichalaf, C.; Schneider-Gold, C.; Nguyen, H.; Wang, G.L.; Albrecht, J.H.; Timchenko, L.T. Ectopic expression of cyclin d3 corrects differentiation of dm1 myoblasts through activation of rna cug-binding protein, cugbp1. Exp. Cell Res. 2008, 314, 2266-2278.
46. Jones, K.; Wei, C.; Iakova, P.; Bugiardini, E.; Schneider-Gold, C.; Meola, G.; Woodgett, J.; Killian, J.; Timchenko, N.A.; Timchenko, L.T. Gsk3beta mediates muscle pathology in myotonic dystrophy. J. Clin. Investig. 2012, 122, 4461-4472.
47. Paul, S.; Dansithong, W.; Kim, D.; Rossi, J.; Webster, N.J.; Comai, L.; Reddy, S. Interaction of muscleblind, cug-bp1 and hnrnp h proteins in dm1-associated aberrant ir splicing. EMBO J. 2006, 25, 4271-4283.
48. Krol, J.; Fiszer, A.; Mykowska, A.; Sobczak, K.; de Mezer, M.; Krzyzosiak, W.J. Ribonuclease dicer cleaves triplet repeat hairpins into shorter repeats that silence specific targets. Mol. Cell 2007, 25, 575-586.
49. Ebralidze, A.; Wang, Y.; Petkova, V.; Ebralidse, K.; Junghans, R.P. Rna leaching of transcription factors disrupts transcription in myotonic dystrophy. Science 2004, 303, 383-387.
50. Greenstein, P.E.; Vonsattel, J.P.; Margolis, R.L.; Joseph, J.T. Huntington's disease like-2 neuropathology. Mov. Disord. 2007, 22, 1416-1423.
51. Margolis, R.L.; O'Hearn, E.; Rosenblatt, A.; Willour, V.; Holmes, S.E.; Franz, M.L.; Callahan, C.; Hwang, H.S.; Troncoso, J.C.; Ross, C.A. A disorder similar to huntington's disease is associated with a novel cag repeat expansion. Ann. Neurol. 2001, 50, 373-380.
52. Paradisi, I.; Ikonomu, V.; Arias, S. Huntington disease-like 2 (hdl2) in venezuela: Frequency and ethnic origin. J. Hum. Genet. 2013, 58, 3-6.
53. Rudnicki, D.D.; Holmes, S.E.; Lin, M.W.; Thornton, C.A.; Ross, C.A.; Margolis, R.L. Huntington's disease-like 2 is associated with cug repeat-containing rna foci. Ann. Neurol. 2007, 61, 272-282.
54. Wilburn, B.; Rudnicki, D.D.; Zhao, J.; Weitz, T.M.; Cheng, Y.; Gu, X.; Greiner, E.; Park, C.S.; Wang, N.; Sopher, B.L.; et al. An antisense cag repeat transcript at jph3 locus mediates expanded polyglutamine protein toxicity in huntington's disease-like 2 mice. Neuron 2011, 70, 427-440.
55. Seixas, A.I.; Holmes, S.E.; Takeshima, H.; Pavlovich, A.; Sachs, N.; Pruitt, J.L.; Silveira, I.; Ross, C.A.; Margolis, R.L.; Rudnicki, D.D. Loss of junctophilin-3 contributes to huntington disease-like 2 pathogenesis. Ann. Neurol. 2012, 71, 245-257.
56. Reamon-Buettner, S.M.; Cho, S.H.; Borlak, J. Mutations in the 3'-untranslated region of gata4 as molecular hotspots for congenital heart disease (chd). BMC Med.Genet. 2007, 8, 38.
57. Menabo, S.; Balsamo, A.; Baldazzi, L.; Barbaro, M.; Nicoletti, A.; Conti, V.; Pirazzoli, P.; Wedell, A.; Cicognani, A. A sequence variation in 3' utr of cyp21a2 gene correlates with a mild form of congenital adrenal hyperplasia. J. Endocrinol. Investig. 2012, 35, 298-305.
58. Abrahams, Y.; Laguette, M.J.; Prince, S.; Collins, M. Polymorphisms within the col5a1 3'-utr that alters mrna structure and the mir608 gene are associated with achilles tendinopathy. Ann. Hum. Genet. 2013, 77, 204-214.
59. Haas, U.; Sczakiel, G.; Laufer, S.D. Microrna-mediated regulation of gene expression is affected by disease-associated snps within the 3'-utr via altered rna structure. RNA Biol. 2012, 9, 924-937.
60. Lee, Y.S.; Dutta, A. The tumor suppressor microrna let-7 represses the hmga2 oncogene. Genes Dev. 2007, 21, 1025-1030.
61. Mayr, C.; Bartel, D.P. Widespread shortening of 3' utrs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 2009, 138, 673-684.
62. Mayr, C.; Hemann, M.T.; Bartel, D.P. Disrupting the pairing between let-7 and hmga2 enhances oncogenic transformation. Science 2007, 315, 1576-1579.
63. Carninci, P.; Kasukawa, T.; Katayama, S.; Gough, J.; Frith, M.C.; Maeda, N.; Oyama, R.; Ravasi, T.; Lenhard, B.; Wells, C.; et al. The transcriptional landscape of the mammalian genome. Science 2005, 309, 1559-1563.
64. Sandberg, R.; Neilson, J.R.; Sarma, A.; Sharp, P.A.; Burge, C.B. Proliferating cells express mrnas with shortened 3' untranslated regions and fewer microrna target sites. Science 2008, 320, 1643-1647.
65. Lembo, A.; Di Cunto, F.; Provero, P. Shortening of 3'utrs correlates with poor prognosis in breast and lung cancer. PLoS One 2012, doi:10.1371/journal.pone.0031129
66. Wiestner, A.; Tehrani, M.; Chiorazzi, M.; Wright, G.; Gibellini, F.; Nakayama, K.; Liu, H.; Rosenwald, A.; Muller-Hermelink, H.K.; Ott, G.; et al. Point mutations and genomic deletions in ccnd1 create stable truncated cyclin d1 mrnas that are associated with increased proliferation rate and shorter survival. Blood 2007, 109, 4599-4606.
67. Hrstka, R.; Coates, P.J.; Vojtesek, B. Polymorphisms in p53 and the p53 pathway: Roles in cancer susceptibility and response to treatment. J. Cell. Mol. Med. 2009, 13, 440-453.
68. Stacey, S.N.; Sulem, P.; Jonasdottir, A.; Masson, G.; Gudmundsson, J.; Gudbjartsson, D.F.; Magnusson, O.T.; Gudjonsson, S.A.; Sigurgeirsson, B.; Thorisdottir, K.; et al. A germline variant in the tp53 polyadenylation signal confers cancer susceptibility. Nature Genet. 2011, 43, 1098-1103.
69. Zhou, L.; Yuan, Q.; Yang, M. A functional germline variant in the p53 polyadenylation signal and risk of esophageal squamous cell carcinoma. Gene 2012, 506, 295-297.
70. Li, Y.; Gordon, M.W.; Xu-Monette, Z.Y.; Visco, C.; Tzankov, A.; Zou, D.; Qiu, L.; Montes-Moreno, S.; Dybkaer, K.; Orazi, A.; et al. Single nucleotide variation in the tp53 3' untranslated region in diffuse large b-cell lymphoma treated with rituximab-chop: A report from the international dlbcl rituximab-chop consortium program. Blood 2013, 121, 4529-4540.
71. Enciso-Mora, V.; Hosking, F.J.; Di Stefano, A.L.; Zelenika, D.; Shete, S.; Broderick, P.; Idbaih, A.; Delattre, J.Y.; Hoang-Xuan, K.; Marie, Y.; et al. Low penetrance susceptibility to glioma is caused by the tp53 variant rs78378222. Br. J. Cancer 2013, 108, 2178-2185.
72. Akman, B.H.; Can, T.; Erson-Bensan, A.E. Estrogen-induced upregulation and 3'-utr shortening of cdc6. Nucleic Acids Res. 2012, 40, 10679-10688.
73. Kazazoglou, T.; Tsiapalis, C.M.; Havredaki, M. Polyadenylate polymerase activity in stationary and growing cell cultures. Exp. Cell Biol. 1987, 55, 164-172.
74. Scorilas, A.; Talieri, M.; Ardavanis, A.; Courtis, N.; Dimitriadis, E.; Yotis, J.; Tsiapalis, C.M.; Trangas, T. Polyadenylate polymerase enzymatic activity in mammary tumor cytosols: A new independent prognostic marker in primary breast cancer. Cancer Res. 2000, 60, 5427-5433.
75. Xu, N.; Chen, C.Y.; Shyu, A.B. Modulation of the fate of cytoplasmic mrna by au-rich elements: Key sequence features controlling mrna deadenylation and decay. Mol. Cell. Biol. 1997, 17, 4611-4621.
76. Hollis, G.F.; Gazdar, A.F.; Bertness, V.; Kirsch, I.R. Complex translocation disrupts c-myc regulation in a human plasma cell myeloma. Mol. Cell. Biol. 1988, 8, 124-129.
77. Eick, D.; Piechaczyk, M.; Henglein, B.; Blanchard, J.M.; Traub, B.; Kofler, E.; Wiest, S.; Lenoir, G.M.; Bornkamm, G.W. Aberrant c-myc rnas of burkitt's lymphoma cells have longer half-lives. EMBO J. 1985, 4, 3717-3725.
78. Young, L.E.; Dixon, D.A. Posttranscriptional regulation of cyclooxygenase 2 expression in colorectal cancer. Curr. Colorectal Cancer Rep. 2010, 6, 60-67.
79. zur Hausen, H. Human papillomaviruses and their possible role in squamous cell carcinomas. Curr. Top. Microbiol. Immunol. 1977, 78, 1-30.
80. Schwarz, E.; Freese, U.K.; Gissmann, L.; Mayer, W.; Roggenbuck, B.; Stremlau, A.; zur Hausen, H. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985, 314, 111-114.
81. Yee, C.; Krishnan-Hewlett, I.; Baker, C.C.; Schlegel, R.; Howley, P.M. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am. J. Pathol. 1985, 119, 361-366.
82. Jeon, S.; Lambert, P.F. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of e6 and e7 mrnas: Implications for cervical carcinogenesis. Proc. Natl. Acad. Sci. USA 1995, 92, 1654-1658.